Infective endocarditis shows an aging patient population and more acute presentations. Despite these changes, improved outcomes and decreased mortality are observed, particularly with timely valve replacement.
Area of Science:
Cardiology
Infectious Diseases
Clinical Medicine
Context:
Longitudinal study comparing infective endocarditis (IE) over three phases (1947-1979).
Analysis of 101 patients in phase III (1975-1979) against earlier cohorts.
Focus on changes in disease course, clinical presentation, and patient outcomes.
Purpose:
To evaluate temporal trends and evolving characteristics of infective endocarditis.
To assess the impact of modern medical interventions on IE outcomes.
To document changes in clinical presentation, etiology, and mortality.
Summary:
Significant increase in average patient age and a rise in acute and postoperative IE cases.
Subacute presentations are decreasing; clinical signs like fever and murmurs are often absent or subtle.
Emergence of right-heart endocarditis, particularly in intravenous drug abusers, presenting with atypical symptoms.
Streptococci and staphylococci remain primary pathogens; blood culture negativity remains high (35%).
Despite increased acute cases, overall mortality has declined, highlighting the benefit of urgent valve replacement.
Impact:
Demonstrates a shift towards older patients and more acute IE presentations.
Highlights the challenge of diagnosing IE due to oligosymptomatic presentations.
Underscores the improved prognosis and reduced mortality associated with timely cardiac valve surgery.
Provides insights into the changing epidemiology and management of infective endocarditis over three decades.